参考文献/References:
[1] 周霜,张京,叶盈,等.恶性肿瘤患者自杀风险评估量表的初步编制[J].中国全科医学,2019,22(9):1062-1066.
[2] GILLETT C,FANTL V,SMITH R,et al.Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining[J].Cancer research,1994,54(7):1812-1817.
[3] 高原.Pim-1激酶抑制剂的设计合成以及构效关系的研究
[D].北京:北京化工大学,2016.
[4] 张彤,徐勇,张淑敏,等.Pim-1在前列腺癌组织中的表达及与血清PSA的关系[J].中国男科学杂志,2005,19(3):19-21.
[5] 段爱霞,陈晶,刘宏德,等.分子对接方法的应用与发展[J].分析科学学报,2009,25(4):473-477.
[6] 赵晨,夏春光,于敏,等.分子对接软件在药物设计中的应用[J].中国抗生素杂志,2015,40(3):234-240.
[7] 赵丽琴,肖军海,李松.分子对接在基于结构药物设计中的应用[J].生物物理学报,2002(3):263-270.
[8] MORRIS G M,GOODSELL D S,HALLIDAY R S,et al.Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function[J].Computers & Chemistry,1998,19(14):1639-1662.
[9] PETTERSEN E F,GODDARD T D,HUANG C C,et al.UCSF chimera-a visualization system for exploratory research and analysis[J].Journal of Computational Chemistry,2004,25(13):1605-1612.
[10] GOOD A C,LIU J,HIRTH B,et al.Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drugdesign[J].Journal of Medicinal Chemistry,2012,55(6):2641-2648.